BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11744428)

  • 1. Pattern and persistence of the epitope-specific IgM response against human cytomegalovirus in renal transplant patients.
    Müller TF; Gicklhorn D; Jungraithmayr T; Eickmann M; Lange H; Radsak K; Reschke M
    J Clin Virol; 2002 Feb; 24(1-2):45-56. PubMed ID: 11744428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral immune response against human cytomegalovirus (HCMV)-specific proteins after HCMV infection in lung transplantation as detected with recombinant and naturally occurring proteins.
    van Zanten J; Harmsen MC; van der Giessen M; van der Bij W; Prop J; de Leij L; The TH
    Clin Diagn Lab Immunol; 1995 Mar; 2(2):214-8. PubMed ID: 7535179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pattern of the epitope-specific IgG/IgM response against human cytomegalovirus in patients with multiple myeloma.
    Bogner E; Pecher G
    Clin Vaccine Immunol; 2013 Aug; 20(8):1298-304. PubMed ID: 23784854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgM-specific serodiagnosis of acute human cytomegalovirus infection using recombinant autologous fusion proteins.
    Vornhagen R; Hinderer W; Sonneborn HH; Bein G; Matter L; The TH; Enders G; Jahn G; Plachter B
    J Virol Methods; 1996 Jun; 60(1):73-80. PubMed ID: 8795008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel Western blot test containing both viral and recombinant proteins for anticytomegalovirus immunoglobulin M detection.
    Lazzarotto T; Maine GT; Dal Monte P; Ripalti A; Landini MP
    J Clin Microbiol; 1997 Feb; 35(2):393-7. PubMed ID: 9003603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral immune response to human cytomegalovirus infection: diagnostic potential of immunoglobulin class and IgG subclass antibody response to human cytomegalovirus early and late antigens.
    Weber B; Braun W; Cinatl J; Doerr HW
    Clin Investig; 1993 Apr; 71(4):270-6. PubMed ID: 8386033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different profiles of cytomegalovirus RNA transcripts and anti-cytomegalovirus IgM antibodies in renal transplant recipients.
    Goossens VJ; Vink C; Mullers W; Middeldorp JM; Bruggeman CA
    J Clin Virol; 2001 Dec; 23(1-2):87-95. PubMed ID: 11595587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment and validation of an enzyme-linked immunosorbent assay for IgG antibody against cytomegalovirus based on pp150 antigen.
    Xi H; Jinjie L; Shengxiang G; Tingdong L; Han W; Xiaoyi G; Tong-Ming F; Jun Z
    J Virol Methods; 2017 Feb; 240():21-25. PubMed ID: 27825854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B cell epitope of human cytomegalovirus phosphoprotein 65 (HCMV pp65) induced anti-dsDNA antibody in BALB/c mice.
    HoHsieh A; Wang CM; Wu YJ; Chen A; Chang MI; Chen JY
    Arthritis Res Ther; 2017 Mar; 19(1):65. PubMed ID: 28320458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgM antibody detection of ppUL80A and ppUL32 by immunoblotting: an early parameter for recurrent cytomegalovirus infection in renal transplant recipients.
    Kraat YJ; Stals FS; Christiaans MH; Lazzarotto T; Landini MP; Bruggeman CA
    J Med Virol; 1996 Mar; 48(3):289-94. PubMed ID: 8801292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin A and M patterns to human cytomegalovirus during recurrent infection in patients with AIDS using a modified western blot.
    Braun W; Weber B; Moell U; Hamann A; Doerr HW
    J Virol Methods; 1993 Jun; 43(1):65-75. PubMed ID: 8395539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening of blood donors for human cytomegalovirus (HCMV) IgG antibody with an enzyme immunoassay using recombinant antigens.
    Weber B; Fall EM; Berger A; Doerr HW
    J Clin Virol; 1999 Dec; 14(3):173-81. PubMed ID: 10614854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular fine-specificity analysis of antibody responses to human cytomegalovirus and design of novel synthetic-peptide-based serodiagnostic assays.
    Greijer AE; van de Crommert JM; Stevens SJ; Middeldorp JM
    J Clin Microbiol; 1999 Jan; 37(1):179-88. PubMed ID: 9854087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of antibodies against the antigen domain 2 epitope of cytomegalovirus (CMV) glycoprotein B is associated with CMV disease after renal transplantation in recipients having the same glycoprotein H serotypes as their donors.
    Ishibashi K; Tokumoto T; Shirakawa H; Hashimoto K; Ikuta K; Kushida N; Yanagida T; Shishido K; Aikawa K; Toma H; Inoue N; Yamaguchi O; Tanabe K; Suzutani T
    Transpl Infect Dis; 2011 Jun; 13(3):318-23. PubMed ID: 20804536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The next generation recombinant human cytomegalovirus vaccine candidates-beyond gB.
    Lilja AE; Mason PW
    Vaccine; 2012 Nov; 30(49):6980-90. PubMed ID: 23041121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of serological diagnosis of human cytomegalovirus infection in renal transplant recipients by testing for specific immunoglobulin E by ELISA.
    Weber B; Stemmler A; Ernst W; Scheuerman EH; Braun W; Doerr HW
    Infection; 1993; 21(3):158-63. PubMed ID: 8396070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of T-Track® CMV to assess the functionality of cytomegalovirus-reactive cell-mediated immunity in hemodialysis patients.
    Banas B; Böger CA; Lückhoff G; Krüger B; Barabas S; Batzilla J; Schemmerer M; Köstler J; Bendfeldt H; Rascle A; Wagner R; Deml L; Leicht J; Krämer BK
    BMC Immunol; 2017 Mar; 18(1):15. PubMed ID: 28270092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody responses to rhesus cytomegalovirus glycoprotein B in naturally infected rhesus macaques.
    Yue Y; Zhou SS; Barry PA
    J Gen Virol; 2003 Dec; 84(Pt 12):3371-3379. PubMed ID: 14645918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human cytomegalovirus (HCMV)-specific T cell but not neutralizing or IgG binding antibody responses to glycoprotein complexes gB, gHgLgO, and pUL128L correlate with protection against high HCMV viral load reactivation in solid-organ transplant recipients.
    Lilleri D; Zelini P; Fornara C; Zavaglio F; Rampino T; Perez L; Gabanti E; Gerna G
    J Med Virol; 2018 Oct; 90(10):1620-1628. PubMed ID: 29797330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of human cytomegalovirus (HCMV) pp67-mRNA and pp65 antigenemia in relation to development of clinical HCMV disease in renal transplant recipients.
    Degré M; Kristiansen KI; Rollag H; Holter E; Nordal KP
    Clin Microbiol Infect; 2001 May; 7(5):254-60. PubMed ID: 11422252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.